Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Inappropriate schedule of product administration, Insomnia, Memory impairment, Migraine
Clinical narrative: Endometriosis, chronic fatigue; Polycystic Ovary Syndrome (PCOS); severe migraines/disabling body pain/chronic fatigue/chronic headaches/difficulty concentrating/memory issue/insomnia/fibromyalgia symptoms/tingling and numbness in her fingers and feet; severe migraines/upon standing heart races, heart rate rises/dizzy/lightheaded/chronic headaches/chronic fatigue/insomnia/autonomic injuries/neurological injuries; autoimmune injuries; seizures/neurological injuries; tested positive for HPV high risk E6/E7 mRNA following her Gardasil vaccination; she received her first and second dosages of Gardasil. She received a third dose when she was 23; Information has been received from a lawyer regarding a case in litigation and refers to an adult female patient (pt) (exact age not provided). The patient's medical history, concurrent conditions and concomitant medications were not provided.  On unknown dates, at the age of 12 years old, the pt was vaccinated with the first and the second dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) as recommended by physician, with her mother's consent, for prophylaxis (also reported as "touted as a safe and effective vaccine for preventing cervical cancer"). On an unspecified date, at the age of 23, the pt was vaccinated with the third dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) as recommended by physician, for the same indication (Inappropriate schedule of product administration).  On unknown dates, following her third vaccination with quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), the pt experienced severe migraines and seizures. Upon standing, her heart raced and her heart rate raised, she was becoming dizzy and lightheaded. The pt experienced disabling body pain, chronic fatigue, chronic headaches, insomnia, difficulty concentrating, memory issues, tingling and numbness in her fingers and feet, and fibromyalgia symptoms. She also tested positive for human papilloma virus (HPV) high risk E6/E7 mRNA following her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)  vaccination. As a result of her post-quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was unable to engage in activities that a young person her age would normally enjoy. She was happy and able to handle basic daily living tasks, but at that time these tasks were difficult, and her symptoms interfered with her ability to work. As the months progressed, so did the pt's symptoms. She was seen by multiple physicians and specialists for her complaints. Based upon her chronic and severe post- quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, she was diagnosed with various medical conditions, including but not limited to endometriosis and polycystic ovary syndrome (PCOS). The pt contended that quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) caused her to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to endometriosis, polycystic ovary syndrome (PCOS), dysautonomia and fibromyalgia symptoms, severe migraines, seizures, disabling body pain, chronic fatigue, insomnia, difficulty concentrating, memory issues, and tingling and numbness in her fingers and feet, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), the patient suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of endometriosis, PCOS, fibromyalgia, dysautonomia, autoimmune disorder, seizure, and tested positive for HPV high risk E6/E7 mRNA was considered as not recovered.  The events of endometriosis, PCOS, fibromyalgia, dysautonomia, autoimmune disorder, seizure, and tested positive for HPV high risk E6/E7 mRNA were considered as related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).   Upon internal review, the events of PCOS, autoimmune disorder and seizure were considered to be medically significant. The reporter considered endometriosis, PCOS, fibromyalgia, dysautonomia, autoimmune disorder, seizure, and tested positive for HPV high risk E6/E7 mRNA as disabling events.